SEARCH

SEARCH BY CITATION

References

  • 1
    Brocklehurst JC. Urinary incontinence in the community—analysis of a MORI poll. BMJ 1993;306: 832834.
  • 2
    Keane DP, Eckford SD, Shepherd AM, Abrams P. Referral patterns and diagnoses in women attending urodynamic unit. BMJ 1992;305: 808.
  • 3
    Bo K, Talseth T, Holme I. Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ 1999;318: 487493.
  • 4
    Cammu H, Van Nylen M. Pelvic floor muscle exercises: 5 years later. Urology 1995;45: 113117.
  • 5
    Klaskov P, Belving D, Bishoff N, et al. Pelvic floor exercise versus surgery for female urinary stress incontinence. Urol Int 1986;41: 129132.
  • 6
    Ulmsten U, Hendriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anaesthesia for treatment of female urinary incontinence. Int Urogynaecol J 1996;7: 8186.
  • 7
    Ward K, Hilton P. Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ 2002;325: 6770.
  • 8
    Netten A, Dennett J, Knight J. Unit Costs of Health and Social Care. Canterbury : PSSRU, University of Kent at Canterbury, 2000.
  • 9
    Review Body for Nursing Staff Midwives, Health Visitors and Professions Allied to Medicine. Report 2000. London : HMSO, 2000.
  • 10
    Review Body on Doctors' and Dentists' Remuneration. Report 2000 London : HMSO, 2000.
  • 11
    British National Formulary. Number 39 (March). London : British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2000.
  • 12
    Sculpher MJ. Economic evaluation of minimal access surgery: the case of surgical treatment for menorrhagia [PhD thesis]. Uxbridge : Brunel University, 1996.
  • 13
    The Chartered Institute of Public Finance and Accountancy (CIPFA). The Health Service Database. Croydon : CIPFA, 1999.
  • 14
    Kind P. The EuroQol instrument: an index of health-related quality of life. In: SpilkerB editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia , Pennsylvania : Lippincott-Rivera, 1996: 191201
  • 15
    Kind P, Hardman G Macran S. UK population norms for EQ-5D. Centre for Health Economics Discussion Paper 172. York: Centre for Health Economics, University of York, 1999.
  • 16
    Matthews JNS, Altman D, Campbell MJ. Analysis of serial measurements in medical research. BMJ 1990;300: 230235.
  • 17
    Orenstein D, Kaplan R. Measuring the quality of well-being in cystic fibrosis and lung transplantation: the importance of the area under the curve. Chest 1991;100: 10161018.
  • 18
    Stata Statistical Software: Release 6.0 (program). College Station, Texas: Stata, 1999
  • 19
    Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York : Chapman & Hall, 1993.
  • 20
    Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med 1996;15: 14471458.
  • 21
    Rubin DB. Multiple Imputation for Non-Response in Surveys. New York : Wiley, 1987.
  • 22
    Schafer JL. Analysis of Incomplete Multivariate Data. London : Chapman & Hall, 1997.
  • 23
    Little RJA, Rubin DB. Statistical Analysis with Missing Data. New York : Wiley, 1987.
  • 24
    Van Hout BA, Al MJ, Gordon GS, Rutten FFH. Costs, effects and C/E ratios alongside a clinical trial. Health Econ 1994;3: 309319.
  • 25
    UK Prospective Diabetes Study GroupCost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998;317: 720726.
  • 26
    Gray A, Raikou M, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 2000;320: 13731378.
  • 27
    Delaney BC, Wilson S, Roalfe A, et al. Cost-effectiveness of an initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet 2000;356: 19651969.
  • 28
    Briggs AH. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998;7: 723740.
  • 29
    Briggs AH. A Bayesian approach to stochastic cost-effectiveness analysis. Health Econ 1999;8: 257261.
  • 30
    National Institute for Clinical Excellence, www.nice.org.uk.
  • 31
    Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The quality of reporting in published cost–utility analyses, 1976–1997. Ann Intern Med 2000;132: 964972.
  • 32
    Majeed AW, Troy G, Nicholl JP, et al. Randomised, prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy. Lancet 1996;347: 989994.
  • 33
    Kung RC, Lie K, Lee P, Drutz HP. The cost-effectiveness of laparoscopic versus abdominal Burch procedures in women with urinary stress incontinence. J Am Assoc Gynecol Laparosc 1996;3: 537544.
  • 34
    Loveridge K, Malouf A, Kennedy C, Edgington A, Lam A. Laparoscopic colposuspension: is it cost-effective?. Surg Endosc 1997;11: 762765.
  • 35
    Kohli N, Jacobs PA, Szw EHM, Roat TW, Karram MM. Open compared with laparoscopic approach to Burch colposuspension: a cost analysis. Obstet Gynecol 1997;90: 411415.